Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Metastatic Colorectal Cancer (First BEAT Brazilian Extension)
NCT01169558Phase 3Completed
- Sponsor
- Roche
- Start
- May 2006
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal cancer (metastatic) (mCRC), sponsored by Roche. Started May 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01169558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169558.